Biora Therapeutics, Inc. (BIOR) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts BIOR Hot Sheet
Join SI Premium – FREE
Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Corpay agrees to $100M FTC settlement over marketing practices
- Can global equities keep rising? UBS sees these factors driving upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
